ATE8044T1 - (3sr, 4rs)-3-((rs)-1-hydroxyaethyl)- und ((rs)-1-acyloxy[thyl)-2-oxo-4-azetidinessigsaeur - verbindungen und verfahren zu deren herstellung. - Google Patents

(3sr, 4rs)-3-((rs)-1-hydroxyaethyl)- und ((rs)-1-acyloxy[thyl)-2-oxo-4-azetidinessigsaeur - verbindungen und verfahren zu deren herstellung.

Info

Publication number
ATE8044T1
ATE8044T1 AT81100185T AT81100185T ATE8044T1 AT E8044 T1 ATE8044 T1 AT E8044T1 AT 81100185 T AT81100185 T AT 81100185T AT 81100185 T AT81100185 T AT 81100185T AT E8044 T1 ATE8044 T1 AT E8044T1
Authority
AT
Austria
Prior art keywords
azetidineacetive
hydroxyaethyl
thyl
acyloxy
oxo
Prior art date
Application number
AT81100185T
Other languages
English (en)
Inventor
Thomas M.H. Liu
David G. Melillo
Kenneth M. Ryan
Ichiro Shinkai
Meyer Sletzinger
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE8044T1 publication Critical patent/ATE8044T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT81100185T 1980-01-14 1981-01-13 (3sr, 4rs)-3-((rs)-1-hydroxyaethyl)- und ((rs)-1-acyloxy[thyl)-2-oxo-4-azetidinessigsaeur - verbindungen und verfahren zu deren herstellung. ATE8044T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/112,035 US4287123A (en) 1980-01-14 1980-01-14 Synthesis of thienamycin via (3SR, 4RS)-3-((RS)-1-acyloxyethyl)-2-oxo-4-azetidineacetate
EP81100185A EP0032400B1 (de) 1980-01-14 1981-01-13 (3SR, 4RS)-3-((RS)-1-Hydroxyäthyl)- und - ((RS)-1-Acyloxyäthyl)-2-oxo-4-azetidinessigsäure-Verbindungen und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE8044T1 true ATE8044T1 (de) 1984-07-15

Family

ID=22341785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81100185T ATE8044T1 (de) 1980-01-14 1981-01-13 (3sr, 4rs)-3-((rs)-1-hydroxyaethyl)- und ((rs)-1-acyloxy[thyl)-2-oxo-4-azetidinessigsaeur - verbindungen und verfahren zu deren herstellung.

Country Status (10)

Country Link
US (1) US4287123A (de)
EP (1) EP0032400B1 (de)
JP (2) JPS56150058A (de)
AT (1) ATE8044T1 (de)
DE (1) DE3164243D1 (de)
DK (1) DK12281A (de)
ES (1) ES8205767A1 (de)
GR (1) GR73108B (de)
IE (1) IE50681B1 (de)
PT (1) PT72333B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414155A (en) * 1980-01-14 1983-11-08 Merck & Co., Inc. Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid
US4383946A (en) * 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
AU548727B2 (en) * 1981-03-12 1986-01-02 Gruppo Lepetit S.P.A. Beta-lactam acetic acid derivatives
US4473502A (en) * 1981-04-08 1984-09-25 Merck & Co., Inc. Synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid
US4360684A (en) * 1981-04-08 1982-11-23 Merck & Co., Inc. Process for the preparation of (2S)-tetrahydro-2α-methyl-6-oxo-4βα-carboxylic acid
US4454332A (en) * 1981-04-17 1984-06-12 Merck & Co., Inc. Hydroxy amino dicarboxylic acids and esters
DE3276316D1 (en) * 1981-08-27 1987-06-19 Fujisawa Pharmaceutical Co Carbapenam compound and processes for the preparation thereof
CA1190236A (en) * 1981-10-23 1985-07-09 Edward J.J. Grabowski Antibiotic synthesis
HU185081B (en) * 1981-12-30 1984-11-28 Richter Gedeon Vegyeszet Process for preparing azetidinone-acetic acid derivatives
JPS58174376A (ja) * 1982-04-08 1983-10-13 Toyama Chem Co Ltd D―ヘキソピラノース誘導体
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
HU190404B (en) * 1982-07-30 1986-09-29 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing amino-lactone-carboxylic acid
JPS5946265A (ja) * 1982-08-24 1984-03-15 Sankyo Co Ltd アゼチジノン誘導体の製造法
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
HU188913B (en) * 1983-06-23 1986-05-28 Richter Gedeon Vegyeszeti Gyar,Rt,Hu Process for producing new azetidinyl-acetic acid esters
HU194203B (en) * 1984-08-15 1988-01-28 Richter Gedeon Rt Process for producing amino-lactone
GB8531638D0 (en) * 1985-12-23 1986-02-05 Ici Plc Chemical compounds
GB8605413D0 (en) * 1986-03-05 1986-04-09 Ici Plc Chemical compounds
SG45180A1 (en) * 1987-02-17 1998-01-16 Ciba Geigy Ag A process for the manufacture of 4-acetoxy-3- hydroxy-ethyl-azetidinone
US5312914A (en) * 1987-02-17 1994-05-17 Ciba-Geigy Corp Process for the manufacture of 4-acetoxy-3-hydroxyethyl-azetidinone
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
JP2503247B2 (ja) * 1988-04-01 1996-06-05 三共株式会社 アゼチジノン誘導体
US5241064A (en) * 1989-10-02 1993-08-31 Fujisawa Pharmaceutical Co., Ltd. Enzymatic process for preparing optically active 3-substituted azetidinones
JPH03123770A (ja) * 1989-10-06 1991-05-27 Mercian Corp アゼチジノン誘導体及びその製法
DE69432777T2 (de) * 1993-02-12 2004-03-18 Daiichi Suntory Pharma Co., Ltd. Verfahren zur synthese von 4-substituierten azetidinon-derivaten
US5493018A (en) * 1994-01-25 1996-02-20 Merck & Co., Inc. Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid
KR100874589B1 (ko) 2007-04-18 2008-12-16 성균관대학교산학협력단 페넴 중간체의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994888A (en) * 1973-06-18 1976-11-30 Eli Lilly And Company Cephalosporin cleavage process
US4008229A (en) * 1974-07-11 1977-02-15 Eli Lilly And Company Halo substituted β-lactam antibiotics
US4008230A (en) * 1975-10-29 1977-02-15 Eli Lilly And Company Process for preparing 3-hydroxy cephalosporins
US4089956A (en) * 1976-09-08 1978-05-16 Smithkline Corporation 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof
GB2006195B (en) * 1977-09-30 1982-03-17 Kyowa Hakko Kogyo Kk 2-azetidinone derivatives

Also Published As

Publication number Publication date
PT72333A (en) 1981-02-01
IE50681B1 (en) 1986-06-11
JPS56150058A (en) 1981-11-20
JPH046704B2 (de) 1992-02-06
US4287123A (en) 1981-09-01
EP0032400B1 (de) 1984-06-20
ES498502A0 (es) 1982-07-01
DE3164243D1 (en) 1984-07-26
PT72333B (en) 1982-07-23
IE810052L (en) 1981-07-14
GR73108B (de) 1984-02-02
EP0032400A1 (de) 1981-07-22
ES8205767A1 (es) 1982-07-01
JPH0144700B2 (de) 1989-09-29
JPH02170A (ja) 1990-01-05
DK12281A (da) 1981-07-15

Similar Documents

Publication Publication Date Title
ATE8044T1 (de) (3sr, 4rs)-3-((rs)-1-hydroxyaethyl)- und ((rs)-1-acyloxy[thyl)-2-oxo-4-azetidinessigsaeur - verbindungen und verfahren zu deren herstellung.
ATE46333T1 (de) Lichtempfindliche, trichlormethylgruppen aufweisende verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltendes lichtempfindliches gemisch.
DK518683D0 (da) Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden
ATE48137T1 (de) Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ATE14126T1 (de) Verfahren zur herstellung von 2-acyl1,3,4,6,7,11b-2h-hexahydro-4-pyrazino(2,1a)isochinolinonen und zwischenprodukte.
ATE49955T1 (de) Substituierte derivate von n|thyl(meth)acrylamid, und verfahren zu ihrer herstellung.
ATE30714T1 (de) Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel und zwischenprodukte.
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
ATE42542T1 (de) 3-amino-azetidin, seine salze, verfahren zu deren herstellung und zwischenprodukte.
ATE13669T1 (de) 4-aryloxy-3-phenylpiperidin-derivate, zwischenprodukte, verfahren zur herstellung solcher verbindungen und ihre verwendung als arzneimittel.
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
ATE30020T1 (de) Verfahren zur herstellung von acemetacin.
DE3789249D1 (de) Verfahren zur Behandlung eines lichtempfindlichen farbphotographischen Halogenidmaterials.
ATE18560T1 (de) Cephemderivate und verfahren zu ihrer herstellung.
ATE6502T1 (de) Verfahren zur herstellung von n-(1'alkoxycarbonyl[thyl)-2,6-dialkylanilinen.
SE8202787L (sv) Forfarande for avlegsnande av formylgruppen fran n-formylpeptider och estrar derav
EP0055907A3 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
ATE27281T1 (de) Verfahren zur herstellung von oxanosin.
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
ATE225T1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
ATE5136T1 (de) Verfahren zur herstellung von n-(1'alkoxycarbonyl[thyl)-2,6-dialkylanilinen.
RO79454A (ro) Procedeu pentru prepararea unor diuretani
SE8207479D0 (sv) A process for the preparation of new bicyclic compound

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee